The latest closing stock price for Chemomab Therapeutics as of April 17, 2025 is 1.12.
An investor who bought $1,000 worth of Chemomab Therapeutics stock at the IPO in 2019 would have $-994 today, roughly -1 times their original investment - a -56.82% compound annual growth rate over 6 years.
The all-time high Chemomab Therapeutics stock closing price was 172.80 on February 12, 2019.
The Chemomab Therapeutics 52-week high stock price is 2.55, which is 127.7% above the current share price.
The Chemomab Therapeutics 52-week low stock price is 0.60, which is 46.4% below the current share price.
The average Chemomab Therapeutics stock price for the last 52 weeks is 1.42.
An investor who bought $1,000 worth of Chemomab Therapeutics stock at the IPO in 2019 would have $-994 today, roughly -1 times their original investment - a -56.82% compound annual growth rate over 6 years.
The all-time high Chemomab Therapeutics stock closing price was 172.80 on February 12, 2019.
The Chemomab Therapeutics 52-week high stock price is 2.55, which is 127.7% above the current share price.
The Chemomab Therapeutics 52-week low stock price is 0.60, which is 46.4% below the current share price.
The average Chemomab Therapeutics stock price for the last 52 weeks is 1.42.